Overview

A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

Status:
Completed

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess whether risperidone (an antipsychotic medication) is safe and effective in treating behaviour disorder in learning disabled children, which does not improve with psychological therapy.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen-Cilag Ltd.

Treatments:

Risperidone